New findings show Vitamin D levels may affect survival after bowel cancer surgery

Research published in the BMJ’s Gut Journal has suggested a link between Vitamin D levels at the time of bowel cancer surgery and long-term survival rates.

The findings are of real importance to researchers, suggesting that Vitamin D is a modifiable risk factor in bowel cancer, and could be used to enhance treatment and save more lives.

The team who carried out this initial research have recently won a BDRF grant to look at vitamin D supplementation around the time of bowel cancer surgery.

The new study is the first step in developing a way to introduce simple Vitamin D tablets as a safe and cost-effective supplement to surgery.

If successful, it could launch a major research trial and ultimately improve patients’ chances of long-term survival.

Peter Vaughan-Shaw, the surgeon leading the study, says:

Vitamin D shows great promise as a cheap and safe supplement to improve survival from bowel cancer yet no other study has looked at vitamin D supplementation around the time of bowel cancer surgery and perioperative levels.

We hope information from this study will help us design a larger study to test whether giving Vitamin D supplements can improve survival following bowel cancer surgery”

Read the full open access publication in Gut here

Vaughan-Shaw PGZgaga LOoi LY, et al
Low plasma vitamin D is associated with adverse colorectal cancer survival after surgical resection, independent of systemic inflammatory response
Top